FT. LEE, N.J. (JUNE 19, 2013) – Astellas Pharma Inc. (http://www.astellas.com/worldwide.html), a pharmaceutical company dedicated to improving the health of people around the world through innovative and reliable pharmaceutical products, has joined SAFE-BioPharma Association, the non-profit industry coalition responsible for the on-going development and implementation of the global SAFE-BioPharma® digital identity and signature standard.
Annual SAFE-BioPharma State of Association WebEx Scheduled for 10AM – Noon EDT, Thursday, June 27
Fort Lee, NJ (June 18, 2013) -- SAFE-BioPharma’s annual State of the Association WebEx will take place 10AM – Noon (EDT), Thursday, June 27.
Equifax Identity Proofing Platform Achieves Level of Assurance 3 FICAM Recognition
ATLANTA, April 18, 2013 — Equifax Inc. (NYSE: EFX), a leading provider of identity authentication services and fraud mitigation solutions to major organizations in the public sector, finance, and healthcare industries, today announced that its Identity Proofing platform has been approved as an Identity Proofing Component member of the SAFE-BioPharma Trust Framework.
ARXSPAN NOW SERVICING SAFE-BIOPHARMA COMMUNITY
Fort Lee, NJ (April 2, 2013) – Arxspan, the developer of the web-based ArxLab electronic laboratory notebook (ELN), has joined with SAFE-BioPharma Association to provide services that can facilitate research collaboration within the community of biopharmaceutical companies comprising SAFE-BioPharma’s members.
NOMINATIONS SOUGHT FOR ANNUAL SAFE-BIOPHARMA "DIGI" AWARDS
Ft. Lee, NJ (March 27, 2013) -- Nominations are now being accepted for the annual SAFE-BioPharma “Digi” Awards recognizing innovative uses of the global SAFE-BioPharma® digital identity and digital signature standards and the institutions and individuals contributing to broader understanding of their benefits.
SAFE-BioPharma OKs Verizon Medical ID Cyber-Credentials As Compliant with US Standards
Fort Lee, NJ (January 22, 2013) – SAFE-Biopharma® has approved the Verizon entity providing high-assurance identity credentials to healthcare professionals as being compliant with US government cyber-trust requirements.
NEW IDENTITY CREDENTIAL IN CLOUD LETS MOBILE DEVICES SECURELY AUTHENTICATE IDENTITY AND APPLY DIGITAL SIGNATURES FROM ANY INTERNET CONNECTION ›
FORT LEE, NJ (December 12, 2012) -- SAFE-BioPharma has introduced a new, globally portable digital identity credential that allows any computer including tablets, smart phones and other mobile devices to assert a digital identity and to securely apply high assurance digital signatures to electronic documents.
US GOVERNMENT OKs SAFE-BIOPHARMA® AS TRUST FRAMEWORK PROVIDER ›
Fort Lee, NJ (November 13, 2012) – The US Government has given SAFE-BioPharma Association the green light to serve as one of four government-approved Trust Framework Providers (TFP) available to Credential Service Providers and Identity Providers issuing cyber-identity credentials.
Peter Alterman Named COO, SAFE-BioPharma Association ›
Fort Lee, NJ (August 9, 2012) – Peter Alterman, PhD., who held numerous senior information security positions within the U.S. federal government, has been named Chief Operating Officer of SAFE-BioPharma Association, the strategic, non-profit collaboration responsible for the global SAFE-BioPharma® digital identity and digital signature standard used in the life science and healthcare sectors.
KAREN BIEN, PFIZER, ELECTED TO BOARD OF DIRECTORS, SAFE-BIOPHARMA ASSOCIATION ›
FT. LEE, N.J. (June 26, 2012) – Karen Bien, director, Business Technology, in Pfizer's Acquisition, Collaboration, and Divestiture team, has been elected to the board of directors of SAFE-BioPharma Association, the strategic non-profit collaboration that developed and manages the global SAFE-BioPharma® digital identity and digital signature standard for the life science and healthcare sectors.
HighQ certified compliant with the SAFE-BioPharma digital identity and signature standard - offering secure digital signatures to the life sciences industry ›
London, 11 June 2012 – HighQ announced today that its secure document exchange and collaboration platform, HighQ Collaborate, has been certified compliant with the SAFE-BioPharma® digital identity and signature standard.
Nation's Leading Identity Trust Hubs Pledge to Expand Use of Digital Identities by Public and Private Sector Employees ›
Washington, D.C. (May 3, 2012) -- A unique cooperative agreement intended to help federal and private-sector employees improve efficiencies and reduce costs by expanding use of their existing cyber-identities has been signed by the nation’s leading identity trust hubs.
RECIPIENTS OF 2012 SAFE-BIOPHARMA "DIGI" AWARDS NAMED ›
Fort Lee, NJ (April 25, 2012) -- Recipients have been selected for the 2012 SAFE-BioPharma Digi Awards recognizing innovative uses of the global SAFE-BioPharma® digital identity and digital signature standard and the institutions and individuals contributing to broader understanding of its benefits.
SAFE-BioPharma Named Computerworld Laureate ›
Fort Lee, NJ (March 20, 2012) -- SAFE-BioPharma®, the global digital identity and digital signature standard for the life sciences and healthcare sectors, has been named a 2012 Computerworld Laureate.
EXPERTS EXPLAIN ROLE OF DIGITAL IDENTITES IN TRANSFORMING HEALTHCARE TO FULLY ELECTRONIC ENVIRONMENT ›
Fort Lee, New Jersey ( February 17, 2012) -- A new publication explains how standards-based interoperable digital identities are needed to transform healthcare to a paperless and fully electronic business environment. It is being issued in conjunction with the annual meeting of Healthcare Information and Management Systems Society (HIMSS), February 20-24 in Las Vegas.
Liaison Technologies Announces Partnership with SAFE-BioPharma ›
ATLANTA — Feb. 7, 2012 — Liaison Technologies, a global provider of secure cloud-based integration and data management services and solutions, announced today a partnership with SAFE-BioPharma Association.
SAFE-BioPharma® Standard to be Highlighted at Molecular TriCon ›
Fort Lee, NJ (February 3, 2012) -- The role of SAFE-BioPharma interoperable digital identities in assuring secure cloud computing will be featured at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference, Sunday, February 19, at Moscone Center in San Francisco.
THREE MAJOR IT TRENDS WILL SHAPE LIFE SCIENCES IN 2012 ›
Fort Lee, NJ (January 19, 2012) -- Three IT trends will shape the life sciences in 2012, according to an analysis by SAFE-BioPharma Association.
SANTA SERENADES SAFE-BIOPHARMA IN UNIQUE MUSICAL GREETING ›
FT. LEE, NJ (DECEMBER 14, 2011) -- An original musical holiday greeting www.safe-biopharma.org/Holiday_Greeting_2011 is available for viewing from SAFE-BioPharma, the global standard for digital trust
HighQ partners with SAFE-BioPharma® Association - offering secure digital signatures to the life sciences industry ›
London, 30 November 2011 – HighQ, a leading provider of secure document exchange and team collaboration software today announced it's vendor partnership with the SAFE-BioPharma® Association, a non-profit organisation that manages the SAFE-BioPharma® digital identity and signature standard for the biopharmaceutical and healthcare industries.
SAVARA INC. JOINS SAFE-BIOPHARMA ASSOCIATION ›
FT. LEE, N.J. (November 21, 2011) – Savara Pharmaceuticals (http://www.savarapharma.com), an inhalation drug development company targeting niche therapeutic areas, has joined SAFE-BioPharma Association.
NCPDP AND SAFE-BIOPHARMA TO COLLABORATE ON LIFE SCIENCE STANDARDS ›
Scottsdale, AZ and Fort Lee, NJ (October 19, 2011) -- The National Council for Prescription Drug Programs (NCPDP) and SAFE-BioPharma Association announced today a strategic alliance to advance use of their respective standards within the life sciences.
TAIGLE BECOMES SAFE-BIOPHARMA VENDOR PARTNER ›
Irvine, CA (October 18, 2011) –Taigle LLC., today announced it has become a vendor partner of SAFE-BioPharma Association, the non-profit that manages the SAFE-BioPharma® digital identity and signature standard for the biopharmaceutical and healthcare industries.
NOMINATIONS SOUGHT FOR FIRST SAFE-BIOPHARMA DIGITAL IDENTITY AWARDS ›
Ft. Lee, NJ (October 13, 2011) --Nominations are now being accepted for the first SAFE-BioPharma Digital Identity Awards recognizing innovative uses of the global SAFE-BioPharma® digital identity and digital signature standard and the institutions and individuals contributing to broader understanding of its benefits.
SAFE-BioPharma SELECTS VERIZON TO MANAGE DIGITAL IDENTITY SERVICES ›
New York, and Fort Lee, N.J. (June 21, 2011) – SAFE-BioPharma Association and Verizon today announced that they have entered into an agreement in which Verizon will manage the association’s digital identity services and issue SAFE-BioPharma digital credentials to its members.
Innovative Paperless Clinical Trial Study White Paper Now Available ›
Fort Lee, NJ (April 27, 2011) -- A new white paper detailing the successful implementation of an ongoing cloud-based, paperless clinical trial pilot study is available, free, at: http://www.safe-biopharma.org/whitepaperform.htm
Innovative Paperless Clinical Trial Study to be Highlighted Tomorrow when U.S. Commerce Secretary Gary Locke and Senior White House Officials Unveil Administration’s National Strategy for Trusted Identities in Cyberspace ›
Ft. Lee, N.J. (April 14, 2011) -- Using interoperable digital identities, digital signatures and cloud computing accelerates initiation of a clinical trial while lowering its costs, a group of government and industry cancer researchers recently found. They participated in the first phase of a pilot study examining the use of interoperable digital identities and cloud-based digital signatures to eliminate reliance on paper forms in clinical trials.
FOREST LABORATORIES AND ALLERGY ASTHMA RESEARCH INSTITUTE JOIN SAFE-BIOPHARMA ASSOCIATION ›
FT. LEE, N.J. (March 8, 2011) – In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories (NYSE; FRX) and the Allergy Asthma Research Institute, have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
Surety and SAFE-BioPharma Association Partner to Deliver the Market’s Strongest Digital IP Protection Service to the Biopharmaceutical Industry ›
Reston, VA and Fort Lee, NJ (February 10, 2011) -- Surety, LLC and SAFE-BioPharma® Association announced today a partnership that leverages the SAFE-BioPharma digital identity management standard with Surety’s AbsoluteProof® Service.